In a study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters.
An advanced type of radiation therapy at Miami Cancer Institute, part of Baptist Health South Florida, is offering patients ablative MR-guided radiation therapy, which may prolong survival for patients with inoperable pancreatic cancer.
Research from a large international effort shows that 20% of children with cancer who are infected with SARS-CoV-2 develop severe infections.
The National Comprehensive Cancer Network has updated the NCCN: Cancer and COVID-19 Vaccination guidance with information on the third mRNA COVID-19 vaccine.
A study published in JNCCN—Journal of the National Comprehensive Cancer Network demonstrated that among all patients with neuroendocrine tumors, the risk of dying of cancer was higher than that of dying of other causes—but mortality varies by primary tumor site.
A report demonstrates that the Incidence rates for malignant brain and other central nervous system tumors declined by 0.8% annually during 2008 through 2017 in the United States for all ages combined.
A phase II trial led by City of Hope suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
A perspective article by researchers at Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer.
The phase III KEYNOTE-716 trial investigating Keytruda, Merck’s anti-PD-1 therapy, met its primary endpoint of recurrence-free survival for the adjuvant treatment of patients with surgically resected high-risk stage II melanoma.
Scientists at St. Jude Children’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute lymphoblastic leukemia.